Pernod Ricard Stock: Better Cash Flow, Weaker Economics

Pernod Ricard finished fiscal 2026 with an unusual combination of numbers. Sales weakened, recurring operating profit declined and management lowered its expectations for medium-term growth. At the same time, free cash flow increased, cash conversion improved sharply and net debt edged lower.

It is tempting to describe that as a mixed year and move on. For a long-term investor, however, the relationship between those numbers is more interesting than the label. Improving cash flow can be genuinely positive without necessarily telling us that the underlying economics of the business are improving.

MOATEY's latest assessment of Pernod Ricard illustrates that distinction. Following the company's FY26 results, the framework moved the company from Slow Grower to No Grower. Its current Growth assessment fell to 0 out of 15 points, while Financial Health remains much stronger at 14.7 out of 15.

The company is still generating considerable cash. The question is what that cash tells us about the future earning power of the business.

Cash flow improved in a weaker year

Pernod Ricard reported FY26 organic net sales down 3.9%, with reported sales falling 14.2% to €9.4 billion after currency and portfolio effects. Profit from recurring operations declined 5.2% organically and 17.9% on a reported basis to €2.42 billion. Earnings per share fell 19% to €5.85.

Those are clearly weaker operating results. Yet free cash flow increased 6% to approximately €1.2 billion, while cash conversion improved by 17 percentage points to 91%. Net debt also declined slightly, by €65 million.

At first glance, that seems reassuring. Cash ultimately matters more than accounting presentation, so an investor should pay attention when a company converts more of its profits into actual cash.

The problem is that the source of the improvement matters.

Pernod Ricard attributed the stronger cash generation partly to working-capital management, lower finished-goods inventories and a reduction in strategic inventory investment and capital expenditure from recent peaks. These actions can strengthen cash flow without requiring revenue or underlying earning power to improve at the same pace.

That does not make the cash flow less real. It simply means investors should not automatically extrapolate a one-year improvement in cash conversion into a stronger long-term growth profile.

Debt fell, but leverage still became less comfortable

The balance-sheet numbers make the same point from another angle. Pernod Ricard reduced net debt slightly during the year, which would normally be viewed positively. Yet its net debt-to-EBITDA ratio increased to 3.7 times.

There is no contradiction. The absolute amount of debt moved down, but EBITDA weakened enough that debt became larger relative to the earnings available to support it.

This is one reason isolated financial metrics can be deceptive. Debt reduction is useful, but debt sustainability depends partly on the earning capacity underneath it. A company can repay some debt and still become more leveraged in economic terms when profits contract faster.

MOATEY currently assigns Pernod Ricard 14.7 of 15 points for Financial Health, so the framework is not suggesting an immediate balance-sheet crisis. It does, however, identify a minor risk around the ability to repay long-term debt from free cash flow within five years.

The distinction is important. Financial health can remain broadly sound while the margin for error becomes smaller.

The larger problem sits in growth

Pernod Ricard's weakness is concentrated in two of its most important markets. FY26 sales in the United States declined 14%, while China remained under significant pressure. Management now expects FY27 organic sales to be broadly stable and has indicated that medium-term growth through FY29 is likely to land closer to the lower end of its previous 3% to 6% range. Reuters reported that the shares fell more than 6% after the results and outlook. The company's CEO also said the U.S. market offered little growth potential over the next three years.

There are offsets. India remains structurally attractive, ready-to-drink products grew 12% in FY26, and management is continuing to remove costs through its €1 billion efficiency program. The second half also improved relative to the first, with organic sales declining 1.3% compared with a 5.9% decline in H1.

Those details matter because a No Grower classification should not be interpreted as a prediction that Pernod Ricard will never grow again. MOATEY classifications describe the current analytical evidence rather than permanently defining a company. The framework currently sees weak enough multi-year growth evidence that the business no longer fits its prior Slow Grower classification.

This is exactly why MOATEY classifications are more useful when read as context rather than labels. They help frame what type of economic development the investor should expect to investigate next.

MOATEY's valuation changed much more than the share price

The most striking change in the latest MOATEY update is not the classification itself. It is the valuation.

Before the latest fundamental information was incorporated, MOATEY's normal-case intrinsic value estimate for the PER.DE listing stood at 67.23 while the market price was 63.38. That represented a modest estimated margin of safety.

After the new evidence was incorporated, the normal-case intrinsic value estimate moved to approximately 29.64 while the market price stood at 62.22. MOATEY's estimated margin of safety consequently moved to roughly negative 52% and the Valuation assessment fell from 17.4 points to zero.

These are MOATEY framework estimates rather than company-reported facts or price targets. Values used by MOATEY may be subject to proprietary adjustments as part of its company evaluation. Their purpose is to create a consistent analytical framework, not to predict where the share price will trade next month.

The size of the change is still informative. A lower stock price does not automatically make a company cheaper when the estimate of underlying value is moving downward at the same time.

That lesson is especially relevant for businesses coming out of periods of unusually strong demand. Spirits producers benefited from favorable consumption patterns and inventory dynamics during parts of the pandemic period. If the sustainable earnings base is subsequently lower than investors assumed, yesterday's apparently attractive valuation can disappear surprisingly quickly.

Strong brands do not eliminate the need for evidence

Pernod Ricard owns some of the most recognizable names in global spirits, including Jameson, Absolut, Chivas Regal, The Glenlivet and Martell. Brand recognition clearly has economic value. The more difficult investment question is how much durable earning power those brands can produce under changing consumer behavior.

MOATEY currently gives Pernod Ricard 5 of 20 available Moat points. Its current Earnings Power Value versus Net Reproduction Value assessment does not yet provide positive evidence of a clear economic moat under the framework.

That should not be read as a claim that the brands themselves have no value. It means the framework is demanding evidence that brand strength translates into sustainably superior economics after considering the capital required to support the business.

This matters in a period when premium spirits companies are dealing with softer U.S. demand, weakness in China, inventory adjustments and changing consumption preferences. Marketing power remains useful, but it cannot make the underlying demand cycle disappear.

The broader fundamental-analysis question is therefore not whether Pernod Ricard owns good brands. It clearly does. The question is whether those brands can produce enough sustainable growth and return on capital to justify the price investors are currently paying.

What matters from here

The first thing to watch is whether the improvement in second-half sales becomes a genuine recovery rather than simply a less severe decline. The United States and China remain important enough that continued weakness there can overwhelm good performance elsewhere. India and other emerging markets can help, but replacing lost economics in two large premium markets takes time.

Cash generation deserves attention too, but the quality of that cash generation matters. Working-capital improvements and lower investment can support free cash flow for a period. Longer term, investors need revenue, margins and returns on reinvested capital to carry more of the load.

Leverage provides another useful checkpoint. Management wants net debt-to-EBITDA below three times by FY29. Reaching that target through stronger EBITDA would tell a different story from reaching it mainly through reduced investment or aggressive debt repayment while the underlying business remains stagnant.

The latest MOATEY assessment is therefore not arguing that Pernod Ricard has stopped being a viable global spirits company. Its balance sheet remains relatively healthy, its brands remain valuable and the company continues to generate substantial cash.

What changed is the relationship between those strengths and the evidence for future growth. FY26 showed that free cash flow can improve while the long-term investment case becomes less attractive. For investors, that is a useful reminder that cash conversion is one part of business quality, not a substitute for it.